Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease ; volume:11 ; number:1 ; day:20 ; month:2 ; year:2019 ; pages:1-7 ; date:12.2019
Alzheimer's research & therapy ; 11, Heft 1 (20.2.2019), 1-7, 12.2019

Creator
Weston, Philip S. J.
Poole, Teresa
O’Connor, Antoinette
Heslegrave, Amanda
Ryan, Natalie S.
Liang, Yuying
Druyeh, Ronald
Mead, Simon
Blennow, Kaj
Schott, Jonathan M.
Frost, Chris
Zetterberg, Henrik
Fox, Nick C.
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-019-0472-5
URN
urn:nbn:de:101:1-2019032018021460708891
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Weston, Philip S. J.
  • Poole, Teresa
  • O’Connor, Antoinette
  • Heslegrave, Amanda
  • Ryan, Natalie S.
  • Liang, Yuying
  • Druyeh, Ronald
  • Mead, Simon
  • Blennow, Kaj
  • Schott, Jonathan M.
  • Frost, Chris
  • Zetterberg, Henrik
  • Fox, Nick C.
  • SpringerLink (Online service)

Other Objects (12)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Related objects